Paul T Quinlan
General Counsel at Oruka Therapeutics, Inc. (ORKA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $6.8M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 21SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 2,90037,095 held (−7%) | $92.37 | $268K | -11.1% |
| Sep 21SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 3,83233,263 held (−10%) | $93.32 | $358K | -12.0% |
| Sep 21SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 60132,662 held (−2%) | $94.44 | $57K | -13.1% |
| Sep 21SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 2,66729,995 held (−8%) | $95.31 | $254K | -13.8% |
| Sep 15SEC | ORKAOruka Therapeutics, Inc. | Sell | 1,03929,995 held (−3%) | $95.71 | $99K | -14.2% |
| Aug 14SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 3,63079,404 held (−4%) | $106.05 | $385K | -22.6% |
| Aug 14SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 10,43468,970 held (−13%) | $107.14 | $1.1M | -23.4% |
| Aug 14SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 14,69654,274 held (−21%) | $107.97 | $1.6M | -24.0% |
| Aug 14SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 10,20044,074 held (−19%) | $109.11 | $1.1M | -24.7% |
| Aug 14SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 9,19334,881 held (−21%) | $110.00 | $1.0M | -25.4% |
| Aug 14SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 3,84731,034 held (−11%) | $111.14 | $428K | -26.1% |
| Jun 15SEC | ORKAOruka Therapeutics, Inc. | Sell | 73331,034 held (−2%) | $69.69 | $51K | +17.8% |
| Mar 17SEC | ORKAOruka Therapeutics, Inc. | Sell | 73331,767 held (−2%) | $41.30 | $30K | +98.8% |
- Sell
General Counsel Paul T Quinlan sold $268K of ORKA at $92.37 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Paul T Quinlan sold $358K of ORKA at $93.32 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Paul T Quinlan sold $57K of ORKA at $94.44 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Paul T Quinlan sold $254K of ORKA at $95.31 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Paul T Quinlan sold $385K of ORKA at $106.05 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Paul T Quinlan sold $1.1M of ORKA at $107.14 — pre-scheduled 10b5-1 plan sale.